Rezzayo
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $399,141 | 3,348 | 1,504 |
| 2023 | $195,374 | 1,413 | 849 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $270,386 | 129 | 45.5% |
| Food and Beverage | $140,045 | 4,394 | 23.6% |
| Travel and Lodging | $55,730 | 158 | 9.4% |
| Consulting Fee | $50,025 | 42 | 8.4% |
| Unspecified | $50,000 | 1 | 8.4% |
| Education | $28,330 | 37 | 4.8% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Pharmacokinetics and Ex Vivo Sequestration of Rezafungin in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO) | Melinta Therapeutics, LLC | $50,000 | 0 |
Top Doctors Receiving Payments for Rezzayo
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Infectious Disease | Houston, TX | $108,613 | 112 |
| , M.D | Internal Medicine | Augusta, GA | $79,225 | 94 |
| Unknown | — | Kansas City, KS | $77,700 | 16 |
| , D.O | Infectious Disease | Altamonte Springs, FL | $43,996 | 60 |
| , MD | Student in an Organized Health Care Education/Training Program | Shreveport, LA | $34,039 | 46 |
| , MD, PHARMD | Student in an Organized Health Care Education/Training Program | Pittsburgh, PA | $12,801 | 20 |
| , MD | Infectious Disease | Huntsville, AL | $10,840 | 13 |
| , M.D | Infectious Disease | Lansing, MI | $10,253 | 15 |
| , MD | Internal Medicine | Sacramento, CA | $8,592 | 10 |
| , D.O | Infectious Disease | Bay Shore, NY | $8,139 | 11 |
| , MD | Infectious Disease | San Diego, CA | $8,004 | 12 |
| Peter Pappas | Infectious Disease | Birmingham, AL | $7,902 | 6 |
| , MD | Infectious Disease | Fairfax, VA | $7,638 | 27 |
| , M.D | Infectious Disease | Houston, TX | $7,000 | 2 |
| , MD | Internal Medicine | Whitesburg, KY | $6,357 | 12 |
| , MD | Infectious Disease | Minot, ND | $6,217 | 17 |
| , M.D | Infectious Disease | Dallas, TX | $5,021 | 5 |
| , MD | Infectious Disease | Saint Louis, MO | $3,122 | 4 |
| , M.D | Infectious Disease | Torrance, CA | $3,115 | 2 |
| , MD | Internal Medicine | Rancho Cordova, CA | $2,911 | 5 |
| , MD | Internal Medicine | Troy, MI | $2,864 | 9 |
| , MD | Internal Medicine | Boston, MA | $2,832 | 3 |
| , MD | Infectious Disease | Middleton, WI | $2,300 | 1 |
| , M.D | Infectious Disease | Las Vegas, NV | $2,270 | 9 |
| , MD | Infectious Disease | Altamonte Springs, FL | $1,190 | 14 |
Manufacturing Companies
- Melinta Therapeutics, LLC $594,516
Product Information
- Type Drug
- Total Payments $594,516
- Total Doctors 1,940
- Transactions 4,761
About Rezzayo
Rezzayo is a drug associated with $594,516 in payments to 1,940 healthcare providers, recorded across 4,761 transactions in the CMS Open Payments database. The primary manufacturer is Melinta Therapeutics, LLC.
Payment data is available from 2023 to 2024. In 2024, $399,141 was paid across 3,348 transactions to 1,504 doctors.
The most common payment nature for Rezzayo is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($270,386, 45.5% of total).
Rezzayo is associated with 1 research study, including "Pharmacokinetics and Ex Vivo Sequestration of Rezafungin in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)" ($50,000).